@article{f6c68c8b9e4d47c9933ad72d361ec64c,
title = "Recurrent SARS-CoV-2 mutations in immunodeficient patients",
abstract = "Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunodeficient patients are an important source of variation for the virus but are understudied. Many case studies have been published which describe one or a small number of long-term infected individuals but no study has combined these sequences into a cohesive dataset. This work aims to rectify this and study the genomics of this patient group through a combination of literature searches as well as identifying new case series directly from the COVID-19 Genomics UK (COG-UK) dataset. The spike gene receptor-binding domain and N-terminal domain (NTD) were identified as mutation hotspots. Numerous mutations associated with variants of concern were observed to emerge recurrently. Additionally a mutation in the envelope gene, T30I was determined to be the second most frequent recurrently occurring mutation arising in persistent infections. A high proportion of recurrent mutations in immunodeficient individuals are associated with ACE2 affinity, immune escape, or viral packaging optimisation.There is an apparent selective pressure for mutations that aid cell–cell transmission within the host or persistence which are often different from mutations that aid inter-host transmission, although the fact that multiple recurrent de novo mutations are considered defining for variants of concern strongly indicates that this potential source of novel variants should not be discounted.",
keywords = "convergent evolution, genomics, immunodeficiency, persistent infection, SARS-CoV-2, variant emergence",
author = "Wilkinson, {S. A. J.} and Beatrix Kele and Peacock, {Thomas P.} and Robson, {Samuel C.} and Connor, {Thomas R.} and Loman, {Nicholas J.} and Tanya Golubchik and {Martinez Nunez}, {Rocio T.} and David Bonsall and Andrew Rambaut and Snell, {Luke B.} and Rich Livett and Catherine Ludden and Sally Corden and Eleni Nastouli and Gaia Nebbia and Ian Johnston and Katrina Lythgoe and {Estee Torok}, M. and Goodfellow, {Ian G.} and Prieto, {Jacqui A.} and Kordo Saeed and Jackson, {David K.} and Catherine Houlihan and Dan Frampton and Hamilton, {William L.} and Witney, {Adam A.} and Giselda Bucca and Pope, {Cassie F.} and Catherine Moore and Thomson, {Emma C.} and Harrison, {Ewan M.} and Smith, {Colin P.} and Fiona Rogan and Beckwith, {Shaun M.} and Abigail Murray and Dawn Singleton and Kirstine Eastick and Sheridan, {Liz A.} and Paul Randell and Jackson, {Leigh M.} and Ariani, {Cristina V.} and S{\'o}nia Gon{\c c}alves and Spurgin, {Lewis G.} and Samir Dervisevic and Mather, {Alison E.} and Rachael Stanley and Davidson, {Rose K.} and Steven Rudder and Alex Richter and Anna Casey and Husam Osman and Mirza, {Jeremy D.} and Joanne Stockton and Josh Quick and Liz Ratcliffe and Natalie Sparks and Nicola Cumley and Radoslaw Poplawski and Nicholls, {Samuel N.} and Beatrix Kele and {The COVID-19 Genomics UK (COG-UK) Consortium} and Peacock, {Thomas P.} and Loman, {Nicholas J.}",
note = "Funding Information: COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) [grant code: MC_PC_19027], and Genome Research Limited, operating as the Wellcome Sanger Institute.",
year = "2022",
doi = "10.1093/ve/veac050",
language = "English",
volume = "8",
journal = "Virus Evolution",
issn = "2057-1577",
publisher = "Oxford University Press",
number = "2",
}